Literature DB >> 1148923

Biochemical criteria for the evaluation of drug efficiency on adjuvant arthritis and nephrotoxic serum nephritis in the rat: studies with phenylbutazone, L-Asparaginase, colchicine, lysine acetylsalicylate, and pyridinol carbamate.

M Sternberg, J Peyroux, A Grochulski, R Engler, J Feret, M Moisy, G Lagrue, M F Jayle.   

Abstract

The levels of serum orosomucoid, haptoglobin, and seromucoid were evaluated as possible quantitative criteria for the estimation of drug efficiency in adjuvant arthritis and nephrotoxic serum nephritis. In adjuvant arthritis, haptoglobin, seromucoid, and chiefly orosomucoid serum levels were generally very sensitive to anti-inflammatory agents such as phenylbutazone and pyridinol carbamate, and to immunosuppressive agents such as L-asparaginase. There was a significant correlation between the serum levels of these glycoproteins and the arthritis scores. In nephrotoxic serum nephritis, seromucoid levels were correlated with the proteinuria of the autologous phase and were found to be a good complementary criterion for the analysis of the efficiency of pyridinol carbamate, colchicine, iysine acetylsalicylate, and L-asparaginase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1148923     DOI: 10.1139/y75-053

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat.

Authors:  H Kurokawa; K Sakamoto
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

Review 2.  Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs?

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1982-10

3.  Naringin in Combination with Isothiocyanates as Liposomal Formulations Potentiates the Anti-inflammatory Activity in Different Acute and Chronic Animal Models of Rheumatoid Arthritis.

Authors:  Sangeeta Mohanty; Ashish Kumar Sahoo; V Badireenath Konkimalla; Abhisek Pal; Sudam Chandra Si
Journal:  ACS Omega       Date:  2020-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.